The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT
SOD and SCD in Egypt
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Accepted: April 8, 2022
Authors
Background: Oxidative stress plays a pivotal role in the pathophysiology of sickle cell
disease (SCD) and its associated disease complications. Superoxide Dismutases (SODs) are
protective enzymes against oxidative stress. SOD2 deficiency results in the accumulation of
oxidized red cell proteins, increased rate of hemoglobin oxidation, decreased red cell membrane
deformability, and subsequently decreased red cells survival.
Objective: The current study was designed to determine the effect of SOD2 Val16Ala gene
polymorphism (rs4880) on SOD2 level and their possible impact on SCD disease severity in a
cohort of Egyptian SCD patients.
Methods: Genotyping SOD2 Val16Ala polymorphism by TaqMan allelic discrimination assay for
hundred SCD patients and a hundred age-sex matched healthy controls revealed the genotypic
and allelic frequencies of the studied polymorphism in the SCD patients were close to that of the
controls.
Results: Serum SOD2 level was significantly lower in those having the polymorphic genotypes
(p=0.005). SOD2 level inversely correlates with the annual rate of hospitalization (r=-0.023, p=
0.038).
Conclusion: SOD2 Val16Ala polymorphism was associated with low serum SOD2 levels that may
predict disease severity.
KEYWORDS. SCD, EGYPT, SOD2, POLYMORPHISM.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
